In the USA, a blood test is offered that can detect 50 types of cancer: where and at what price it is done - ForumDaily
The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

In the USA, a blood test is offered that can detect 50 types of cancer: where and at what price it is done

The Mayo Clinic is developing a revolutionary blood test that can detect over 50 different types of cancer at all stages. The edition told in more detail Fox Business.

Photo: Shutterstock

A test known as Gallerywas created in partnership with Menlo Park, a California-based biotech and pharmaceutical company called Grail.

During blood sampling, Galleri looks in the bloodstream for signals that may be associated with cancer.

The test uses next-generation sequencing and machine learning algorithms to analyze patterns of extracellular DNA (cfDNA) methylation in the bloodstream, which may carry cancer-specific information.

DNA methylation is a process used by cells to regulate gene expression. If a cancer signal is detected, Galleri will pinpoint where the cancer is originating in the body to help healthcare providers determine the appropriate course of action to treat the patient.

On the subject: With Chemotherapy, Cancer Patients Can Save Their Hair: A Simple Method Few Heard Of

Currently, recommended cancer screenings in the United States cover only five different types of cancer and can only detect one type at a time. According to Grail, 71% of cancer deaths are caused by cancers that are not usually screened.

Galleri, which is not covered by insurance, costs $ 949 and must be ordered by a licensed healthcare provider, such as a doctor, nurse practitioner, or paramedic. Grail says Galleri currently has 89% accuracy in predicting the origin of cancer, and estimates that about 1 in every 200 people will have a false-positive result.

You may be interested in: top New York news, stories of our immigrants and helpful tips about life in the Big Apple - read it all on ForumDaily New York

Results usually come about two weeks after the blood is drawn. Galleri is recommended for adults with an increased risk of cancer, such as those aged 50 and over, and should be used in addition to other standard cancer screening tests such as colonoscopy or mammography.

Grail is currently working to obtain full Galleri approval from the US Food and Drug Administration (FDA).

Read also on ForumDaily:

How and how much you can earn from participating in clinical trials

The pace of development of artificial intelligence frightens even scientists: how smart robots threaten humanity

How to get rid of annoying automatic calls: 8 simple and effective ways

Tasty and healthy: how to save money on food and learn English

Asset or money: what is cryptocurrency and how safe is it

18 ghost cities in America that give goosebumps

In the U.S. cancer analysis
Subscribe to ForumDaily on Google News

Do you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram  and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis. 



 
1087 requests in 1,156 seconds.